Fatima F

References (2)

Title : FDA Approval of Donanemab-azbt: A New Dawn in Alzheimer's Disease Treatment - Riaz_2026_Health.Sci.Rep_9_e72688
Author(s) : Riaz R , Fatima M , Ramzan S , Rathi D , Fatima F , Farooq M , Shaukat A , Khaliq N , Akilimali A
Ref : Health Sci Rep , 9 :e72688 , 2026
Abstract :
PubMedSearch : Riaz_2026_Health.Sci.Rep_9_e72688
PubMedID: 42338648

Title : Hibiscetin attenuates lipopolysaccharide-evoked memory impairment by inhibiting BDNF\/caspase-3\/NF-B pathway in rodents - Gilani_2024_PeerJ_12_e16795
Author(s) : Gilani SJ , Bin Jumah MN , Fatima F , Al-Abbasi FA , Afzal M , Alzarea SI , Sayyed N , Nadeem MS , Kazmi I
Ref : PeerJ , 12 :e16795 , 2024
Abstract :
PubMedSearch : Gilani_2024_PeerJ_12_e16795
PubMedID: 38313003